Celgene Corporation (NASDAQ:CELG) reported operational results for the fourth quarter and full year of 2013. For the fourth quarter of 2013, total revenue was $1,756 million compared to $1,447 million in the fourth quarter of 2012, an increase of 21 percent. Net product sales were $1,725 million compared to $1,416 million from the same period in 2012, an increase of 22 percent.
Help employers find you! Check out all the jobs and post your resume.
